Bullish on Optimer Pharma
Yahoo/Zacks.com
Cubist launches drug trial aimed at hospital-acquired infections
Bizjournals.com
Optimer Launches Dificid
Yahoo/Zacks.com
Calls for shake-up to reward antibiotic R&D
Pharma Times, UK
Cubist might stay clear of Ph3 for antibiotic, analyst says
Fierce Biotech

